Revenue of $3,541 million grew 3.0 percent year-over-year on a reported basis and 7.1 percent at constant currency GAAP Net Income of $256 million grew 46.3 percent year-over-year Adjusted EBITDA of $800 million grew 10.8 percent year-over-year GAAP Diluted Earnings per Share of $1.34 grew 48.9 percent year-over-year Adjusted Diluted Earnings per Share of $2.44 … [Read more…]
DENVER–(BUSINESS WIRE)–MedPharm Research, a leading cannabis researcher, announced today that the company’s proposal, which was submitted to the FY23 Cannabis Research Opportunity at the Colorado State University Institute of Cannabis Research (ICR), titled “Isolation and Pharmacological Evaluation of Phytocannabinoids for Alzheimer’s Disease,” has been selected for funding. Scoring of the proposal was organized into six … [Read more…]
Collaboration to kick off at “The Power of a Dream” National Convention in Orlando, Fla. to bridge professional diversity gaps to emphasize importance of health equity for communities of color PRINCETON, N.J.–(BUSINESS WIRE)–$BMY—Bristol Myers Squibb NYSE (BMY) announced the first biopharma three-year exclusive collaboration with the premier African American Family Organization, Jack and Jill of … [Read more…]
SANTA MONICA, Calif.–(BUSINESS WIRE)–FIGS, Inc. (NYSE: FIGS), the direct-to-consumer healthcare apparel and lifestyle brand, today announced it will release its second quarter 2022 financial results on Thursday, August 4, 2022, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial … [Read more…]
LifeWorks Mental Health IndexTM reveals Americans whose employers supported their mental health during the pandemic have highest mental health scores CHICAGO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions, today released its monthly Mental Health IndexTM revealing 63 percent of Americans believe people with mental health conditions are treated differently. Additionally, the … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Biosensors Market: Focus on Drug Discovery and Development – Distribution by Type of Biosensor, Type of End User and Key Geographies – Industry Trends and Global Forecasts, 2022-2035” report has been added to ResearchAndMarkets.com’s offering. At present, various types of biosensors, including optical biosensors, electrochemical biosensors, thermal biosensors and others, are being deployed … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Oncology Information System Market by Application (Medical, Radiation, Surgical Oncology), by Software (Patient Information System, TPS, RIS, PACS, Services), End User (Hospitals, Cancer Care Centers, Government Institution) and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global oncology information systems market size is estimated to be USD … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “In Vitro Diagnostic Market Brief Update” report has been added to ResearchAndMarkets.com’s offering. What Major Trends are Affecting the Market Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from the analysts to reflect the latest information as of Q4 2021. … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Colorectal Cancer Screening Tests Market Analysis by Screening Test (Flexible Sigmoidoscopy, Stool-Based Tests, CT Colonography, Colonoscopy), by End User (Independent Diagnostic Labs, Hospitals), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global colorectal cancer screening tests market size is estimated to be USD 12,994 million in … [Read more…]
NeuroFront receives an exclusive option for an exclusive license to develop, commercialize and manufacture NRD.E1, Novaremed’s first-in-class, non-opioid investigational drug for the treatment of chronic neuropathic pain in Greater China and Singapore Novaremed is entitled to receive a total of over USD 130 million in option and exercise fees as well as development, regulatory and … [Read more…]
